Published online before print March 21, 2002, doi: 10.1161/01.RES.0000015885.27134.F0
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2002 American Heart Association, Inc.
Clinical Research |
Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia
From the Departments of Human Genetics (H.A., P.P., R.M.C., R.M., J.I.R., L.P., A.J.L.), Microbiology and Molecular Genetics (K.L.K., A.J.L.), Medicine (K.L.K., J.I.R., A.J.L.), and Pediatrics (R.M.C., J.I.R.) and the Molecular Biology Institute (A.J.L.), University of California, Los Angeles; the Department of Medicine and the Cardiovascular Research Institute Maastricht (C.J.H.v.d.K., T.W.A.d.B.), Academic Hospital, Maastricht, the Netherlands; and the Division of Medical Genetics (J.I.R.), Steven Spielberg Pediatric Research Center and Cedars-Sinai Research Institute, Los Angeles, Calif.
Correspondence to Hooman Allayee, PhD, Department of Human Genetics, Gonda Genetics Research Center, Room 6524, UCLA School of Medicine, 695 Charles Young Dr South, Los Angeles, CA 90095. E-mail hallayee{at}ucla.edu
Familial combined hyperlipidemia (FCH), a common cause of premature coronary artery disease, is genetically complex and poorly understood. Recently, a major locus on chromosome 1q21-23 exhibiting highly significant linkage was identified in Finnish FCH families by use of a parametric analysis. We now report highly significant evidence of linkage (maximum LOD score 3.8, recombination fraction 0) of an important FCH phenotype, elevated apolipoprotein B (apoB) levels, to a distinctly separate locus on chromosome 1p31 in Dutch pedigrees. ApoB is the major protein on very low density and low density lipoproteins, and elevated apoB levels have been used as a surrogate trait for FCH. Additional microsatellite markers in the 1p31 region were genotyped, and evidence of linkage improved (maximum LOD score 4.7) in a multipoint analysis of two markers in the peak region. The leptin receptor gene resides within this locus and is involved in obesity and insulin/glucose homeostasis. However, there was no evidence of an association between leptin receptor and apoB levels, raising the possibility that another gene on this chromosomal region contributes to elevated apoB levels in this Dutch population. This is one of the first loci identified for apoB levels in humans and is the second major locus implicated in the genetic etiology of FCH.
Key Words: apolipoprotein B • genetics • hyperlipoproteinemia • coronary artery disease
This article has been cited by other articles:
 |
|
 |
|
  J. C. Lee, D. Weissglas-Volkov, M. Kyttala, J. S. Sinsheimer, A. Jokiaho, T. W.A. de Bruin, A. J. Lusis, M.-L. Brennan, M. M.J. van Greevenbroek, C. J.H. van der Kallen, et al. USF1 Contributes to High Serum Lipid Levels in Dutch FCHL Families and U.S. Whites With Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2222 - 2227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. G. J. Brouwers, R. M. Cantor, N. Kono, J. l. Yoon, C. J. H. van der Kallen, M. A. L. Bilderbeek-Beckers, M. M. J. van Greevenbroek, A. J. Lusis, and T. W. A. de Bruin Heritability and genetic loci of fatty liver in familial combined hyperlipidemia J. Lipid Res., December 1, 2006; 47(12): 2799 - 2807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Huertas-Vazquez, C. Aguilar-Salinas, A. J. Lusis, R. M. Cantor, S. Canizales-Quinteros, J. C. Lee, L. Mariana-Nunez, R.-M. L. Riba-Ramirez, A. Jokiaho, T. Tusie-Luna, et al. Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1 Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1985 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bosse, Y. C. Chagnon, J.-P. Despres, T. Rice, D. C. Rao, C. Bouchard, L. Perusse, and M.-C. Vohl Compendium of genome-wide scans of lipid-related phenotypes: adding a new genome-wide search of apolipoprotein levels J. Lipid Res., December 1, 2004; 45(12): 2174 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Cantor, T. de Bruin, N. Kono, S. Napier, A. van Nas, H. Allayee, and A. J. Lusis Quantitative Trait Loci for Apolipoprotein B, Cholesterol, and Triglycerides in Familial Combined Hyperlipidemia Pedigrees Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1935 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lusis, A. M. Fogelman, and G. C. Fonarow Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways Circulation, September 28, 2004; 110(13): 1868 - 1873. [Full Text] [PDF]
|
|
|
|
|
|
A.M. Georgieva, M.M.J. van Greevenbroek, R.M. Krauss, M.C.G.J. Brouwers, V.M.M.-J. Vermeulen, M.G. Robertus-Teunissen, C.J.H. van der Kallen, and T.W.A. de Bruin Subclasses of Low-Density Lipoprotein and Very Low-Density Lipoprotein in Familial Combined Hyperlipidemia: Relationship to Multiple Lipoprotein Phenotype Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 744 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.C. Shoulders, E.L. Jones, and R.P. Naoumova Genetics of familial combined hyperlipidemia and risk of coronary heart disease Hum. Mol. Genet., April 1, 2004; 13(90001): R149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia J. Lipid Res., November 1, 2003; 44(11): 2100 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Allayee, L. W. Castellani, R. M. Cantor, T. W.A. de Bruin, and A. J. Lusis Biochemical and Genetic Association of Plasma Apolipoprotein A-II Levels With Familial Combined Hyperlipidemia Circ. Res., June 13, 2003; 92(11): 1262 - 1267. [Abstract] [Full Text] [PDF]
|
|